EUVIMEDEUVIMED entdecken
Crossref

Manufactured doubt and the EPA 2020 chrysotile asbestos risk assessment

John M Dement, Dana Loomis

American Journal of Industrial Medicine · 2023

DOI: 10.1002/ajim.23476 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Industrial Medicine, 2023. Verfasst von John M Dement und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Occupational and Environmental Medicine, Duke University Medical Center, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Lung Neoplasms, Asbestos, Mesothelioma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While all forms of asbestos have been determined to be carcinogenic to humans by the International Agency for Research on Cancer (IARC) as well as other authoritative bodies, the relative carcinogenic potency of chrysotile continues to be argued, largely in the context of toxic tort litigation. Relatively few epidemiologic studies have investigated only a single form of asbestos; however, one study that included an asbestos textile plant located in Marshville, North Carolina that processed chrysotile asbestos was used by the United States Environmental Protection Agency (EPA) in 2020 to help inform the agency's chrysotile asbestos risk assessment. During the EPA proceedings toxic tort defense consultants submitted comments to the EPA docket and made public presentations asserting that the Marshville plant had processed amphibole asbestos types and should not be used for the chrysotile risk assessment. A detailed evaluation of defense consultant assertions and supporting information and a full assessment of the available information concerning asbestos types used at the Marshville plant was undertaken. The preponderance of evidence continues to support the conclusion that neither amosite nor crocidolite were likely to have been processed in the Marshville textile plant. Defense consultants' assertions about chrysotile use are not supported by the preponderance of evidence and constitute an example of manipulation of information to cast uncertainty and doubt rather than to seek truth and contribute to the body of scientific evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsAsbestosMesotheliomaUnited StatesHumansAsbestos, SerpentineUnited States Environmental Protection AgencyAsbestos, AmphiboleAsbestos, CrocidoliteRisk Assessment

Stichwörter der Autor:innen

asbestoschrysotiledoubt sciencerisk assessmenttextilestort litigation

Substanzen

Asbestos, SerpentineAsbestosAsbestos, AmphiboleAsbestos, Crocidolite

Autor:innen und Institutionen

  • Division of Occupational and Environmental Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Plumas County Public Health Agency, Quincy, California, USA.

Zitieren

APA

Dement, J. M., & Loomis, D. (2023). Manufactured doubt and the EPA 2020 chrysotile asbestos risk assessment. American Journal of Industrial Medicine. https://doi.org/10.1002/ajim.23476

Vancouver

Dement JM, Loomis D. Manufactured doubt and the EPA 2020 chrysotile asbestos risk assessment. American Journal of Industrial Medicine. 2023. doi:10.1002/ajim.23476

BibTeX
@article{Dement2023,
  author = {Dement, John M and Loomis, Dana},
  title = {Manufactured doubt and the EPA 2020 chrysotile asbestos risk assessment},
  journal = {American Journal of Industrial Medicine},
  year = {2023},
  doi = {10.1002/ajim.23476}
}
Kostenlos starten →